oxiconazole
(WVNOAGNOIPTWPT-NDUABGMUSA-N)
Structure
- SMILES
- Clc1ccc(c(c1)Cl)CO/N=C(/c1ccc(cc1Cl)Cl)\Cn1cncc1.[O-][N+](=O)O
- Molecular Formula:
- C18H14Cl4N4O4
- Molecular Weight:
- 492.140
- Log P:
- 6.2933
- Hydrogen Bond Acceptor:
- 4
- Hydrogen Bond Donor:
- 1
- TPSA:
- 105.46
- CAS Number(s):
- 64211-45-6; 64211-46-7
Synonym(s)
1.
oxiconazole
2.
(Z)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-O-(2,4-dichlorobenzyl) ethanone oxime nitrate
3.
2',4'-dichloro-2-imidazol-1-ylacetophenone (Z)-(O-(2,4-dichlorobenzyl)oxime), mononitrate
4.
Fonx
5.
Gyno-Myfungar
6.
Myfungar
7.
Oceral
8.
Oxistat
9.
Oxizole
10.
RO-13-8996
11.
Salongo
12.
Sgd 301-76
13.
oxiconazole mononitrate, (Z)-isomer
14.
oxiconazole nitrate
15.
oxyconazole
External Link(s)
| MeSH | C022155 |
| PubChem Compound | 9556529 |
| ChEBI | 7826 |
| CHEMBL | CHEMBL1200836 |
| KEGG | cpd:C08075 dr:D00885 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 5 | US FAERS | |
| 2 | Pruritus | FAERS: 5 | US FAERS | |
| 3 | Accidental exposure to product | FAERS: 3 | US FAERS | |
| 4 | Expired product administered | FAERS: 3 | US FAERS | |
| 5 | Application site erythema | FAERS: 2 | US FAERS | |
| 6 | Application site pain | FAERS: 2 | US FAERS | |
| 7 | Erythema | FAERS: 2 | US FAERS | |
| 8 | Expired drug administered | FAERS: 2 | US FAERS | |
| 9 | Eye irritation | FAERS: 2 | US FAERS | |
| 10 | Inflammation | FAERS: 2 | US FAERS | |
| 11 | Application site exfoliation | FAERS: 1 | US FAERS | |
| 12 | Application site pruritus | FAERS: 1 | US FAERS | |
| 13 | Application site rash | FAERS: 1 | US FAERS | |
| 14 | Burning sensation | FAERS: 1 | US FAERS | |
| 15 | Dermatitis | FAERS: 1 | US FAERS | |
| 16 | Disorientation | FAERS: 1 | US FAERS | |
| 17 | Dizziness | FAERS: 1 | US FAERS | |
| 18 | Drug administration error | FAERS: 1 | US FAERS | |
| 19 | Dry skin | FAERS: 1 | US FAERS | |
| 20 | Exposure via eye contact | FAERS: 1 | US FAERS | |
| 21 | Headache | FAERS: 1 | US FAERS | |
| 22 | Hypersensitivity | FAERS: 1 | US FAERS | |
| 23 | Pain of skin | FAERS: 1 | US FAERS | |
| 24 | Product substitution issue | FAERS: 1 | US FAERS | |
| 25 | Product use in unapproved indication | FAERS: 1 | US FAERS | |
| 26 | Skin irritation | FAERS: 1 | US FAERS | |
| 27 | Therapeutic response unexpected | FAERS: 1 | US FAERS | |
| 28 | Tinea Pedis | FAERS: 1 | US FAERS | |
| 29 | Visual Impairment | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.